Kenvue has appointed Bas Vorsteveld as Area Managing Director for Northern Europe. He will oversee Kenvue’s business in the ...

Centauri Therapeutics Limited has announced the selection of its first clinical candidate for the ABX-01 programme. The ...

Research from the Blood Cancer Alliance reveals a significant disparity in access to new blood cancer treatments on the NHS.

Grünenthal has announced that Professor Dr Uli Brödl will assume the role of Chief Scientific Officer (CSO) and Member of the ...

Alligator Bioscience has announced updated results from its phase 2 OPTIMIZE-1 study, showing the survival benefits of ...

Dr Michalis Papadakis, CEO and Co-Founder of Brainomix, highlighted the shared vision of both companies: “This partnership ...

To help HCPs find reliable online answers about medicines, Datapharm collaborated with Medical Information Leaders in Europe ...

At its core, the regulation aims to improve transparency and accountability in clinical trials across Europe. For ...

Entering the post-approval phase marks a critical pivot for pharmaceutical companies, shifting their focus from the ...

In a world of multiplying data and discourse, stakeholders across life sciences and healthcare are increasingly struggling to ...

Major medical advances, combined with the proliferation of new technologies, have created opportunities for biopharmaceutical ...

Microbiotica, a clinical-stage biopharma company, has presented new data on MB097 at the AACR IO meeting held in Los Angeles.